Skip to main content

Gonorrhoea clinical trials at UCSD
1 in progress, 0 open to new patients

  • Clinical Validation of a Molecular Test for Ciprofloxacin-Susceptibility in Neisseria Gonorrheaoe

    Sorry, not currently recruiting here

    Data from this clinical study will be used to assess if the treatment approach meets CDC criteria for becoming a recommended treatment (cure rate greater than 95 percent with a lower CI:95percent greater than 95 percent) or alternative treatment (cure rate greater than 95 percent with a lower CI95 percent greater than 90 percent) for uncomplicated gonococcal infection. An estimated cure rate of 0.98. A single-arm clinical study design, allowing for a 10 percent subject drop-out rate and 10 percent non-evaluable rate. Screening Visit will include a NG NAAT; the Baseline Visit at Day 1 will include a NG NAAT and culture; Test of Cure Visit at Day 6 will include a NG NAAT and culture. The primary objective of this study is to determine the efficacy of ciprofloxacin for treatment of uncomplicated N. gonorrhoeae infections with gyrA serine 91 genotype.

    San Diego, California and other locations